OATP1B1 in vitro inhibition assay enrichment & QSAR modeling

被引：0
|
作者：
Danielson, Matthew [1 ]
机构：
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
来源：
DRUG METABOLISM REVIEWS | 2016年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P169
引用
收藏
页码：107 / 107
页数：1
相关论文
共 50 条
  • [41] Impact of OATP1B1 variants on colorectal cancer
    Alpertunga, Buket
    Vefai, Mehtap
    Sari, Fatih
    Ozhan, Gul
    TOXICOLOGY LETTERS, 2012, 211 : S69 - S69
  • [42] OATP1B1 polymorphisms and torsemide pharmacokinetics and pharmacodynamics
    Vormfelde, S. V.
    Toliat, M. R.
    Schirmer, M.
    Meineke, I.
    Nuernberg, P.
    Brockmoeller, J.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2007, 101 (05) : 384 - 384
  • [43] Liver uptake of cefditoren is mediated by OATP1B1 and OATP2B1 in humans and Oatp1a1, Oatp1a4, and Oatp1b2 in rats
    Wang, Hepeng
    Sun, Pengyuan
    Wang, Changyuan
    Meng, Qiang
    Liu, Zhihao
    Huo, Xiaokui
    Sun, Huijun
    Ma, Xiaodong
    Peng, Jinyong
    Liu, Kexin
    RSC ADVANCES, 2017, 7 (48): : 30038 - 30048
  • [44] Interaction of deoxyschizandrin and schizandrin B with liver uptake transporters OATP1B1 and OATP1B3
    Lu, Yanli
    Hu, Qingqing
    Chen, Lin
    Zhang, Hong
    Huang, Shibo
    Xiong, Yuqing
    Xia, Chunhua
    XENOBIOTICA, 2019, 49 (02) : 239 - 246
  • [45] Variability in In Vitro OATP1B1/1B3 Inhibition Data: Impact of Incubation Conditions on Variability and Subsequent Drug Interaction Predictions
    McFeely, Savannah J.
    Ritchie, Tasha K.
    Ragueneau-Majlessi, Isabelle
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2020, 13 (01): : 47 - 52
  • [46] Inhibition of OATP1B1 by tyrosine kinase inhibitors: in vitro-in vivo correlations (vol 110, pg 894, 2014)
    Hu, S.
    Mathijssen, R. H. J.
    de Bruijn, P.
    Baker, S. D.
    Sparreboom, A.
    BRITISH JOURNAL OF CANCER, 2017, 117 (05) : e3 - e3
  • [47] Contribution of hepatic uptake transporters OATP1B1/OATP1B3 to the disposition of docetaxel
    Lee, Hye Jeong
    Leake, Brenda F.
    Teft, Wendy
    Kim, Richard B.
    Ho, Richard H.
    CANCER RESEARCH, 2014, 74 (19)
  • [48] An OATP1B1 Inhibition Assay using Nonradiolabeled Pitavastatin: Important Results and Exploitation of the Assay as a Surrogate for Human Hepatocyte Active Uptake Intrinsic Clearance
    Grime, Ken
    Soars, Matt G.
    Riley, Robert J.
    DRUG METABOLISM REVIEWS, 2009, 41 : 60 - 60
  • [49] Clinical Importance of OATP1B1 and OATP1B3 in Drug-Drug Interactions
    Shitara, Yoshihisa
    DRUG METABOLISM AND PHARMACOKINETICS, 2011, 26 (03) : 220 - 227
  • [50] Contribution of OATP1B1 and OATP1B3 to the Disposition of Sorafenib and Sorafenib-Glucuronide
    Zimmerman, Eric I.
    Hu, Shuiying
    Roberts, Justin L.
    Gibson, Alice A.
    Orwick, Shelley J.
    Li, Lie
    Sparreboom, Alex
    Baker, Sharyn D.
    CLINICAL CANCER RESEARCH, 2013, 19 (06) : 1458 - 1466
12345